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Abstract
Introduction Consensus in sample preparation for untargeted human fecal metabolomics is lacking.
Objectives To obtain sample preparation with broad metabolite coverage for high-throughput LC–MS.
Methods Extraction solvent, solvent ratio and fresh frozen-vs-lyophilized samples were evaluated by metabolite feature 
quality.
Results Methanol at 5 mL per g wet feces provided a wide metabolite coverage with optimal balance between signal inten-
sity and saturation for both fresh frozen and lyophilized samples. Lyophilization did not affect SCFA and is recommended 
because of convenience in normalizing to dry matter.
Conclusion The suggested sample preparation is simple, efficient and suitable for large-scale human fecal metabolomics.
Keywords Fecal sample · Freeze-drying · Method optimization · Short-chain fatty acids · Untargeted fecal metabolomics · 
XCMS
1 Introduction
Untargeted metabolomics aims to comprehensively profile 
the small molecules in a biological system for different pur-
poses, such as disease prediction, studies of mechanisms and 
assessment of the exposome (Karu et al. 2018). Establishing 
robust methods that allow profiling of a wide number of 
metabolites in large-scale sample sets at high throughput 
remains a major challenge (Deda et al. 2015, 2018; Matysik 
et al. 2016).
Research has shown that gut microbiota and their metabo-
lites interact with host metabolism and thereby influence 
host health (Lamichhane et al. 2018). Feces is an attrac-
tive matrix for untargeted profiling that can be easily and 
non-invasively obtained, and is rich in endogenous host 
metabolites as well as metabolites derived from gut micro-
biota and its interaction with xenobiotics, such as bio-trans-
formed food metabolites (Matysik et al. 2016). It was also 
recently shown that the fecal metabolome to a large extent 
reflects the gut microbiota composition and activity and it 
was concluded that fecal metabolomics provides a potential 
to explore links between microbiome composition and the 
host phenotypes (Zierer et al. 2018).
LC–MS-based untargeted metabolomics is a sensi-
tive and widely applied analytical tool, whereas so far, the 
application of LC–MS-based untargeted metabolomics on 
fecal samples is less common than that of NMR or GC–MS 
(Cesbron et al. 2017; Deda et al. 2017; Karu et al. 2018). 
Among existing LC–MS studies (e.g. Cesbron et al. 2017; 
Deda et al. 2017, 2018; Huang et al. 2013; Jiménez-Girón 
et al. 2015; Loftfield et al. 2016; Lopez-Bascon et al. 2019; 
Moosmang et al. 2019; Turroni et al. 2016; Yu et al. 2017; 
Zhao et al. 2012; Zierer et al. 2018), the procedures for 
sample preparation are typically simple, but a standard-
ized protocol for human fecal sample handling in order to 
cover a wide range of metabolites is so far lacking (Deda 
et al. 2015; Karu et al. 2018). Researchers have for instance 
used: (1) Different types of fecal materials, e.g. fecal water 
(Yu et al. 2017), fresh fecal samples (Loftfield et al. 2016), 
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s1130 6-020-01669 -z) contains 
supplementary material, which is available to authorized users.
 * Ken Cheng 
 cheng-ken@live.cn
 * Rikard Landberg 
 rikard.landberg@chalmers.se
1 Division of Food and Nutrition Science, Department 
of Biology and Biological Engineering, Chalmers University 
of Technology, 412 96 Gothenburg, Sweden
 K. Cheng et al.
1 3
46 Page 2 of 8
frozen-thawed fecal samples (Deda et al. 2017; Huang et al. 
2013; Turroni et al. 2016; Zhao et al. 2012) and lyophilized 
fecal samples (Zierer et al., 2018) and; (2) Different solvents 
for fecal metabolites extraction, e.g. MeOH (Huang et al. 
2013; Zierer et al. 2018), acetonitrile (ACN) (Deda et al. 
2018; Zhao et al. 2012), saline water (Jiménez-Girón et al. 
2015), and multiple solvents including  H2O, MeOH, and 
chloroform in different ratios (Lopez-Bascon et al. 2019; 
Moosmang et al. 2019). Various extraction methods have 
been applied for different analytical purpose, e.g. to increase 
coverage of specific metabolite classes, such as lipids, 
amino acids, etc. To the best of our knowledge, only very 
few articles have reported protocol optimization of human 
(Moosmang et al. 2019) and animal (Cesbron et al. 2017; 
Lopez-Bascon et al. 2019) fecal samples adapted for untar-
geted LC–MS-based metabolomics. In brief, these articles 
seem to favor frozen over lyophilized fecal material, sim-
pler sample pre-treatment (Cesbron et al. 2017; Moosmang 
et al. 2019), and extraction using single-phase methanol at a 
feces-solvent-ratio of 1:3 (w/v, Cesbron et al. 2017), water at 
1:5 (w/v, Moosmang et al. 2019), or methanol/water at 1:25 
(w/v, Lopez-Bascon et al. 2019). Additionally, a filtration 
step is usually recommended to reduce the risk of changes 
in metabolic profile and blockage of chromatography instru-
mental lines (Karu et al. 2018), but the effects of filtration 
on metabolites coverage of human fecal samples in LC–MS 
has not been thoroughly evaluated.
Selection of suitable parameters has been based on 
observed peak shapes and baseline performance of TIC and 
Base Peak spectra (Cesbron et al. 2017) or on the number 
of detected signals or identified metabolites (Lopez-Bascon 
et al. 2019; Moosmang et al. 2019). However, these meth-
ods provide only limited information that is not adequate to 
check the coverage of metabolites in detail: In TIC and BPC, 
the assessment of low intensity peaks is not well represented 
by higher-intensity peaks and apparent peak overlap may be 
deconvoluted when examining m/z-resolved data. The total 
number of peaks carries only limited information about peak 
quality and well-defined metabolite subsets do not neces-
sarily reflect the untargeted coverage of the metabolome. 
Given these potential pitfalls, it has become increasingly 
common to investigate the detection of peaks or “features” 
in LC–MS-based untargeted metabolomics studies, since 
they cover a wider range of the measurable metabolome. 
However, to avoid erroneous inference, the total number of 
features should be balanced against other measures for peak/
feature quality (Wang et al. 2019).
Thus, in the current study we aimed to obtain a high-
throughput and robust method with broad coverage of the 
human fecal metabolome from untargeted LC–MS metab-
olomics. We evaluated in particular extraction solvents 
(MeOH, ACN and  H2O), solvent ratio (SR, 1 to 40), fecal 
materials (fresh frozen and freeze-dried fecal sample, FR, 
FD) and the effects of filtration. In these evaluations, we 
have assessed feature quality indirectly, by comparing fea-
tures derived from an XCMS-based pipeline between dif-
ferent protocols. Selected feature parameters included total 
number of features, proportion of missing values and total 
intensities. In addition, given their importance in diet-micro-
biota-health research, we performed a targeted evaluation of 
short chain fatty acids between the different protocols.
2  Materials and method
2.1  Fecal materials
Fecal samples used in the study were obtained from 10 
healthy men and women (5 men and 5 women, Sweden) 
A self-administered collection kit (EasySampler, GP Medi-
cal Devices ApS, Denmark) was used from which a 1–3 g 
sample was taken to a test tube and frozen at − 20 °C imme-
diately after collection until the sample was brought to 
− 80 °C storage at the laboratory within 24 h.
Pooled fecal samples were prepared for the selection of 
solvent ratio (SR; pooled from n = 5 randomly selected indi-
viduals) and extraction solvent (pooled from all 10 individu-
als). For comparisons of metabolic profiles between fresh 
frozen (FR) and freeze-dried (FD) fecal materials, individual 
fecal samples were analyzed (n = 10). All samples were ana-
lyzed in triplicate, except for the solvent ratio test where only 
one replicate was analyzed (Table S1).
2.2  Sample preparation
2.2.1  Selection of solvent ratio
After thawing at 4 °C for 30 min, frozen fecal samples (200, 
150, 60, 30, 30, 30 and 30 mg in wet weight) were lyophi-
lized after weighing and then dissolved in MeOH (200, 300, 
300, 300, 600, 900 and 1200 µL) in solvent ratio (SR) 1:1, 
1:2, 1:5, 1:10, 1:20,1:30 and 1:40 (w/v). Throughout the 
manuscript, we refer to these ratios in a simplified format, 
i.e. SR 1, 2, 5, 10, 20, 30 and 40, respectively.
2.2.2  Selection of solvent and solvent ratio
Fresh frozen and lyophilized fecal samples (60 mg wet 
weight) were dissolved in 300 and 600 µL of either MeOH, 
Acetonitrile (ACN) or  H2O in SR 5 and 10.
2.2.3  Selection of fecal materials
All freeze-drying was conducted overnight (15 h, HetoDry-
wimmer, − 55  °C). Lyophilized samples were weighed 
before and after drying and stored at − 80 °C until analysis. 
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Fresh frozen and lyophilized fecal samples (60 mg in wet 
weight) were dissolved in 300 µL MeOH to get SR 5, vor-
texed at 1600 rpm for 5 min, ultra-sonicated for 30 min at 
room temperature, and vortex again. After centrifugation 
(18,000×g for 15 min at 4 °C), the supernatants were trans-
ferred and stored at − 80 °C until analysis. Prior to transfer-
ring to LC vials, all samples were centrifuged at 18,000×g 
for 30 min at 4 °C. ACN and MeOH in HPLC–MS grade 
(VWR Chemicals), and Milli-Q  H2O which was filtered with 
LC-Pak Polisher (18.2 MΩ at 25 °C, 3–4 ppb TOC, Merck 
Millipore) were used.
When testing the differences between filtered and non-
filtered samples, 96-well Captiva ND plates (1 mL, Agilent) 
and 96-well collection plates (0.45 mL, Nunc. Thermo) were 
applied for filtration.
Blank samples followed by in-house mixtures of external 
standards were injected at the beginning of each sequence 
to monitor baseline instrument performance, including mass 
accuracy and retention time. Quality control samples (QCs) 
were prepared for each test separately, by combining ali-
quots from all extracts. QC samples were injected regularly 
throughout each analytical batch (5 injections at the begin-
ning of run (post external standard mixture) for equilibra-
tion, at the end and at every 6th sample in each sequence) to 
monitor the stability and functionality of the instrumental 
system and to correct for instrumental drift (Brunius et al. 
2016).
2.3  Untargeted HPLC‑MS analysis
Samples were analyzed by UHPLC-QTOF MS using an 
Agilent 1290 Infinity UHPLC system (Santa Clara, CA) 
interfaced to a quadrupole-time-of-flight mass spectrom-
eter (Agilent 6520 accurate-mass) equipped with an elec-
trospray ion source (ESI). The separation of compounds 
was achieved on an Acquity UPLC HSS T3 (C18) col-
umn (1.8 µm, 2.1 × 100 mm, Waters, Ireland) at 45 °C. 
The injection volume was 2 µL. A binary eluent system 
of water (A) and methanol (B), both containing 0.04% of 
formic acid was used at a flow rate of 0.4 mL/min. The 
programmed gradient profile was 0–6 min: 5% to 100% 
B, 6–10.50 min: 100% B, 10.50–10.51 min: 100% to 5% 
B, 10.51–15 min: 5% B. The ESI was operated at 3500 V 
in both positive and negative mode and using nitrogen 
as nebulizing and drying gas. The gas temperature of the 
source was 175 °C, gas flow 12 L/min and the nebulizing 
gas pressure 45 psig. The fragmentor voltage was set at 
170 V and skimmer at 65 V. Reference masses (149.02332 
and 922.009798 in positive mode, and 112.985587 and 
996.000725 in negative mode) were used for mass accu-
racy checking. Mass spectra were recorded from m/z 50 
to m/z 1600. Data were acquired in centroid mode at an 
acquisition rate of 1.67 spectra/s in the Agilent Mass-
Hunter software, and converted to mzML format using 
MSConvert (ProteoWizard 3.0.18285).
2.4  Targeted GC–MS analysis of short‑chain fatty 
acids
We performed a targeted analysis of the short-chain fatty 
acids (SCFA: acetic-, propionic-, butyric-, isobutyric-, 
valeric-, isovaleric- and caproic acid) in fresh frozen and 
lyophilized fecal samples using a GC–MS method to evalu-
ate their potential loss upon freeze-drying. Briefly, 20 mg 
fresh frozen fecal samples were weighed into test tubes. 
Lyophilized fecal samples were obtained by freeze-drying 
overnight (as described above). Samples were then diluted 
in 4 mL MilliQ  H2O and mixed thoroughly with metal 
beads (2 mm) for 5 min. A portion of 400 µL of the super-
natants was mixed with 100 µL meta- phosphoric acid (16% 
w/v in MilliQ  H2O) containing internal standard (15 nmol 
acrylic acid, L04280, Alfa Aesar, USA) for 5 min using a 
vortex. Propyl formate (300 µL) was added to the samples 
and mixed for 5 min. Samples were centrifuged at 16,000 g 
4 °C for 15 min and 150 µL of the upper organic layer was 
collected in GC vials for analysis.
Samples were analyzed by a Shimadzu GC–MS-TQ8030 
(Tokyo, Japan), fast scanning triple quadrupole GC system 
with a PAL autosampler. The sample (2 µL) was injected in 
split-less mode and helium (2 mL/min) was used as carrier 
gas. SCFA were separated on a ZB-FFAP column (30 m, 
0.25 µm ID, no. 7HG-G009-11; Phenomenex, USA). The 
initial oven temperature was set at 40 °C for 1 min, then 
ramped to 250 °C at a rate of 40 °C/min. The final tempera-
ture was held for 2 min giving a total runtime of 8 min per 
sample. Electron impact ionization (250 °C) mode was used. 
Selected ion monitoring was performed with one quantifica-
tion ion and one confirmation ion (m/z), respectively: Acetic 
acid m/z 60 and 45, propionic acid m/z 74 and 57, isobutyric 
acid m/z 73 and 57, butyric acid 73 and 60, isovaleric acid 
m/z 87 and 60, valeric acid m/z 73 and 60, caproic acid 
m/z 73 and 60 and for the internal standard acrylic acid m/z 
72 and 45. Quantification was made based on an 8 point 
standard curve in ranges normally observed in fecal samples: 
10–1280 µM for acetic acid (Honeywell), 4–512 µM for pro-
pionic acid (Alfa Aesar) and butyric acid (Sigma-Aldrich) 
and 0.5–64 µM for the other SCFA (isobutyric acid and 
valeric acid purchased from Alfa Aesar; isovaleric acid and 
caproic acid from Sigma-Aldrich). The SCFA concentrations 
were linearly regressed against the ratio of SCFA/acrylic 
acid. Samples, standards and blanks were analyzed randomly 
by the GC–MS system. Integrations were performed with 
GCMSsolution workstation software (Shimadzu GCMS-TQ 
series).
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2.5  Data pre‑processing
The term ‘feature’ refers to a mass spectral peak, i.e. a 
molecular entity with a unique mass to charge ratio (m/z) 
and retention time (RT) measured by the LC–MS instru-
ment. Data was deconvoluted using the XCMS R package 
v 3.4.1 (Smith et al. 2006). Parameters were optimized 
specifically per experiment from a combination of IPO-
assisted (Libiseller et  al. 2015) and manual optimiza-
tion (Table S2). Signal intensities were first corrected for 
instrument drift using the within-batch correction method 
in “BatchCorr” (Brunius et al. 2016) (Fig. S1) and then 
normalized by fecal dry mass. The features with retention 
time < 660 s and intensity coefficient of variation (CV) in 
QCs < 30% were kept for further evaluation in the selec-
tion of extraction solvents and solvent ratios.
2.6  Statistical analysis
Number of features, percentage of missing values (NA%), 
total intensities of features and CV of feature intensities 
were compared between treatments using paired t-test in R 
v 3.5.1. Extraction solvent and solvent ratio were analyzed 
separately per fecal material (FR and FD) using solvent, 
solvent ratio and their interaction as fixed factors; For 
comparison between FR and FD, fecal material was used 
as a fixed factor and individual (n = 10) as a random factor.
3  Results and discussion
Between 10,000 and 34,000 features were extracted in 
positive and negative ionization mode using xcms. Of 
these, 4000–12,000 features were kept for further evalu-
ation after data filtering (Table S3). This large number 
of features represent a variety of molecular entities, such 
as monoisotopic metabolite ions, isotopes, adducts, frag-
ments, dimers, trimers, instrument-specific ions or random 
noise and thus overestimates the number of actual analytes 
in the sample matrix (Mahieu and Patti 2017). However, 
grouping of features into pseudospectra is known to cre-
ate artefacts (Senan et al. 2019). Thus, we have chosen to 
present the subsequent evaluations on the level of features 
although many of them likely represent the same analyte 
although this may induce over-representation bias. Manual 
inspection showed good performance with reproducible 
retention times and intensities in BPC with satisfactory 
baseline separation and peak shapes in the major peaks of 
QCs, samples and blank samples (Figs. S2a, 2b).
3.1  Selection of solvent ratio and solvents 
for extraction
Solvent ratios up to 1:25 have previously been reported 
(Lopez-Bascon et al. 2019). During our early investiga-
tions using SR 20, we had observed signal saturation for 
some features and therefore extended up to SR 40. Signal 
saturation for these features was, however, not considerably 
improved at higher SRs. With decreasing SR from 40 to 5, 
feature numbers and total intensity of features increased, 
and the proportion of missing values (NA%) decreased in 
both positive and negative ESI mode (Fig. S3). The SR 1 
was not practical for extraction due to a small liquid volume. 
Samples prepared with SR 2 had a higher total intensity 
than SR 5, but slightly lower number of features and higher 
NA% in both positive and negative mode (Fig. S3). Impor-
tantly, several signals at SR 2 at 300–450 s retention were 
saturated, effectively limiting the practical usability of this 
solvent ratio. Therefore, the SR 5 and 10 were chosen for 
further selections.
The choice of solvent affected the number and total 
intensity of detected features as well as the proportion of 
missing values in both fresh frozen and lyophilized samples 
(P < 0.0001; Figs. 1, S4). Methanol resulted in a larger num-
ber of reproducibly detected features compared to ACN and 
 H2O, likely representing a wider coverage of the metabo-
lome. For example, in FD fecal samples at SR 5, 97% of 
all features detected from any extraction solvent showed up 
in MeOH, whereas only 86% and 87% of the features were 
present in ACN and  H2O, respectively (Fig. S5c). Moreo-
ver, the methanol extracts had lower proportion of missing 
values and higher total intensity than extracts of ACN and 
 H2O (Figs. 1, S4). To investigate whether the advantage of 
methanol as an extraction solvent was related to its use as 
mobile phases in the chromatographic system, we visually 
inspected peak shapes. However, we could not observe any 
obvious differences in peak shape between the extraction 
solvents, which could be due to the small injection volume. 
The advantage of methanol as extraction solvent was further 
supported by Cesbron et al. (2017) and Lopez-Bascon et al. 
(2019). However, in opposition to these results, Moosmang 
et al. (2019) instead reported better extraction yield, peak 
shape and metabolite coverage for water, which they there-
fore recommend for extraction solvent, at least for reverse 
phase LC–MS.
Using methanol as extraction solvent also resulted in 
improved repeatability for sample preparation and lin-
earity within conditions used, compared with MeOH/
chloroform (3:1), ACN, ACN/chloroform (3:1) and 
 H2O in a targeted GC–MS analysis (Gao et al. 2010). 
An LC–MS study by Cesbron et al. (2017) found that 
extraction of fresh frozen feces with methanol produced 
better peak shape and baseline in total ion and base peak 
An LC-QToF MS based method for untargeted metabolomics of human fecal samples 
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chromatograms, compared with the extraction of lyophi-
lized feces using multiple solvents (MeOH, chloroform 
and  H2O). Multi-solvent extraction (MeOH/chloroform/
H2O) had higher coverage of metabolites in a semi-tar-
geted NMR study, but is more time-consuming, labor 
intensive, expensive and toxic compared to one-solvent 
extraction (Karu et al. 2018; Moosmang et al. 2019) and 
may also result in poorer chromatography (Cesbron et al. 
2017), lower MS sensitivity and reproducibility (Karu 
et al. 2018). Thus, multi-solvent extraction may not be 
well suited for large-scale sample preparation. As a final 
note to the selection of extraction solvent, Moosmang 
et  al. (2019) noted that that different solvents extract 
different metabolite classes. Consequently, one single 
extraction technique is not sufficient for a holistic over-
view over the entire fecal metabolome. Thus, even if one 
particular extraction solvent may have an advantage in 
terms of general metabolite coverage, other solvents may 
have advantages for the coverage of specific metabolite 
classes and the choice of solvent should correspond to the 
research question at hand as well as the choice of fecal 
collection method (Wang et al. 2018).
We observed no differences between SR 5 and 10 in 
feature numbers or NA%, but total intensity was higher at 
SR 5 (positive ESI mode: P = 0.0838 in FR, P = 0.0103 in 
FD; negative ESI mode: P = 0.0623 in FR and P = 0.0291 
in FD), which should facilitate later identification of com-
pounds by MS/MS (Fig. S6). Similarly, Moosmang et al. 
(2019) reported SR 5 as optimal, since SR 2 was more 
difficult to process due to limited initial quantity or sam-
ple consistency, whereas higher SR 10 led to more diluted 
extracts.
3.2  Comparison between fresh frozen 
and lyophilized fecal samples
Based on the obtained results, extraction with MeOH at SR 
5 was selected for further comparison of fresh frozen vs 
lyophilized fecal samples. After normalization to dry mat-
ter content, features in lyophilized and fresh frozen fecal 
samples had very similar intensities and proportion of miss-
ing values (Figs. 2, S7), although lyophilized fecal samples 
had slightly higher number of features, lower proportion of 
missing values and higher total intensity in both positive 
and negative ESI mode (Table S4). Larger differences in 
number of detected features were instead observed between 
individuals (Fig. S8).
Moosmang et al. (2019) also reported similar number of 
features between lyophilized and fresh frozen fecal samples, 
indicating that the choice of method does not affect metab-
olite coverage appreciably. On the other hand, they also 
reported large discrepancies in signal intensities between 
lyophilized and fresh frozen fecal samples and hypothesized 
that these discrepancies may be related to improved extrac-
tion efficacy for the lyophilized material. Our results, on the 
other hand, indicate that the observed discrepancies may 
instead be related to dry matter content and care should be 
taken to normalize samples to dry matter.
To further investigate systematic occurrence of missing 
values in the data, we compared features exclusively miss-
ing in FD and FR: 95% and 96% of exclusive missing fea-
tures in FD and FR samples were present in ≦ 3 samples in 
both positive and negative modes, indicating that systematic 
missingness according to preparation (FR vs FD) was only a 
minor issue. In fact, only 7 and 9 of all the 12,517 analyzed 
Fig. 1  a NA%, b feature numbers and c log (total intensity) in fresh (FR) and lyophilized (FD) fecal samples using MeOH, ACN and  H2O as 
extraction solvents at solvent ratio (SR) 10 and 5 (n = 3), results in positive electron spray ionization mode
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features were exclusively missing from all FD and FR sam-
ples, respectively (Table S4).
Whether to use fresh frozen or lyophilized samples for 
fecal metabolomics is a matter of debate, since each pro-
cedure may provide advantages and disadvantages. Freeze-
drying has been recommended (Karu et al. 2018; Ng et al. 
2012), because difference in water content in fecal samples 
could have a substantial impact on the analytical outcomes 
not only due to the influence on weight measurement, but 
also due to alterations in the lipophilicity of the extraction 
system. However, some researchers (Deda et al. 2018) pro-
posed that the lyophilization process may increase the risk 
of losing volatile compounds. However, given the similarity 
in intensities between fresh and lyophilized samples in the 
present study, this seems unlikely. SCFA comprise important 
volatile metabolites derived from gut microbial fermentation 
of dietary fiber and their potential health effects beyond their 
established role as fuel for the gut epithelium has received 
much attention lately (Koh et al. 2016). We consequently 
performed a targeted comparison of lyophilized vs fresh 
frozen samples with regards to loss of SCFA. In our study, 
SCFA were extracted and measured from fresh frozen and 
lyophilized fecal samples in parallel. We found no observ-
able difference in their content (Table S6). This observation 
is supported by the biophysical properties of the fatty acids. 
The pKa of SCFA range between 4.76 for acetic acid to 
4.88 for caproic acid (Osuka et al. 2012). The average fecal 
pH for a healthy person is around 6.6, leaving the SCFA 
deprotonated which may limit the evaporation of SCFA in 
feces (Osuka et al. 2012). As expected, when acidifying 
lyophilized fecal samples, lower contents of SCFAs were 
detected compared with fresh frozen samples, suggesting 
evaporation when pH is getting closer to the pKa-values 
of the acids (data not shown). The impact of freeze-drying 
on other volatile metabolites in fecal samples has not been 
specifically investigated in this study.
Given the similarity in feature quality between fresh fro-
zen and lyophilized fecal samples, with a slight advantage 
for lyophilized samples, freeze-drying allows the additional 
advantage to normalize to dry matter, without decreasing 
overall metabolite coverage, which helps to overcome the 
issue with the large variability in water content in feces, such 
as fecal samples from diarrhea and constipation patients. 
Additionally, it has been reported that working with dried 
fecal samples is less laborious, especially for grinding 
(Moosmang et al. 2019), more reproducible and also pre-
vents bacterial growth (Karu et al. 2018).
Moreover, no differences were observed between filtered 
and non-filtered samples regarding chromatogram baseline, 
number of features or proportion of missing values in our 
study. Filtered samples did, however, have higher total inten-
sity of all features than non-filtered (Fig. S9 and Table S7). 
However, without filtration, we observed successively 
increasing back pressure, retention time deviations and ulti-
mately LC failure, most likely from deposition at the inlet 
of column. Our method development therefore suggested 
that the filtration step should be added to improve analytical 
robustness in large-scale analyses. This approach was also 
suggested in a recent review (Karu et al. 2018).
There are limitations in our protocol. In the sample prepa-
ration, the already high intrinsic sample heterogeneity in the 
fecal sample matrix could have been exacerbated by weigh-
ing in different amounts for the different solvent ratios. How-
ever, this seems to be of minor given the associations of 
Fig. 2  Log-transformed intensity of all features in ten fresh (FR) and 
lyophilized (FD) fecal sample (S1–S10). All missing values were set 
to 0.5 before plotting for visual convenience. The red dash lines on 
the figures are predictive interval lines. Results are in positive elec-
tron spray ionization mode
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feature parameters with solvent ratio (Fig. S3). There may 
also be differences in precipitation and extraction efficiency 
in relation to freeze-drying for specific metabolites, however 
systematic effects on the metabolome coverage seem minor 
(Fig. 2). In addition, in our effort to simplify the protocol, 
we only considered pure unmixed solvents and observed that 
almost all of the features detected in water and ACN were 
in fact also detected using methanol. However, the inves-
tigation of simple one-phase solvent mixtures, especially 
water:MeOH, could have contributed additional important 
information, e.g. on signal intensities as a proxy for extrac-
tion efficiency and recovery.
Importantly, to make a full, in-depth assessment of 
method performance and validation such as ion suppression, 
recovery, extraction efficiency, solvent saturation and limit 
of quantification, more direct and targeted methods than the 
ones we have employed are needed. However, a compre-
hensive, direct analysis of a sufficiently large representa-
tive portion of the metabolome required to extend results 
into generalizations valid for the coverage of the untargeted 
metabolome is far beyond the scope of this work. We instead 
chose an indirect methodology consisting of proxy assess-
ment of feature quality, which still represents improvement 
beyond assessing only the total number of features, visual 
inspection of base peak chromatogram including peak shape 
of a sub-selection of major peaks. Another limitation in the 
study design was the omission of procedural blanks, which 
would have permitted accurate assessment of contaminant 
peaks. However, a crude analysis of features that did not dif-
fer in intensity between SR 5 and 10 suggested that potential 
artefacts (from e.g. contaminants and instrumentation) and 
features outside the linear range was consistent between the 
investigated extraction solvents and that these may constitute 
up to approximately 12% of the measured features (Fig S10, 
Table S3). Consequently, the feature quality parameters that 
we employed, albeit highly informative, could consequently 
be biased as metrics of the feature coverage and quality.
In conclusion, we found that MeOH was superior to ACN 
and  H2O for fecal extraction to obtain a wide coverage of 
reproducible, robust metabolite features with high intensity. 
A solvent ratio of 5 mL solvent per g feces (wet weight) 
provided an optimal balance between signal intensity and 
instrument saturation. Fresh frozen and lyophilized fecal 
material showed similar results with regard to number and 
intensity of features as well as proportion of missing val-
ues and content of volatile SCFA. Considering the highly 
variable water content in fecal samples, we therefore suggest 
using lyophilized fecal samples as a convenient approach to 
normalize metabolite feature intensities to dry matter.
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